📈 Jumpstart Signal Watchlist — October 15, 2026

🏢 What they do: Paysign, Inc. is a payments technology company that provides prepaid card programs, integrated payment processing, and digital banking/payment solutions for businesses, healthcare and pharmaceutical clients, and government or consumer payout programs.
- 🎯 At/above 3yr high $15.60 (current $15.60) · ⏳ SMA200 $7.76 (current price $15.60 is above) · 💰 Market Cap $881M
- PAYS shows decent technicals supported by positive sentiment.

💎 Quality (Q): 53/60
- 🏦 EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 450% (>20%); Revenue growth 48% (>15%); ROE 26% (>15%); Low LT D/E 0.06 (<1.0).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (9.4%)
- 🔔 Strong above EMA50 (20.1%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 68 showing strength
📢 Sentiment (S): 8/10
- 🗞️ News sentiment is positive (✅×2 ⚪️×1).
✅ Paysign (NASDAQ:PAYS) Hits New 1-Year High - Time to Buy? — MarketBeat.
🤖 The article notes Paysign reached a new one-year high and cites a generally positive analyst outlook, including a $15 price target and Buy ratings. It also references quarterly results that exceeded consensus expectations.
✅ DA Davidson raises Paysign stock price target to $15 on growth outlook — Investing.com.
🤖 DA Davidson raised its price target from $12 to $15 while maintaining a Buy rating. The article also notes that Paysign beat second-quarter earnings and revenue expectations and raised its full-year outlook.
⚪️ Paysign CEO Mark Newcomer sells $766,895 of PAYS stock — Investing.com.
🤖 The CEO sold 50,000 shares under a Rule 10b5-1 trading plan. This is a reported insider transaction, not by itself a clear directional catalyst for the stock.
🍭 Bonus (B): 0/10 — Business Services

🏢 What they do: OneSpan provides cybersecurity and digital agreement solutions, including identity verification, authentication, fraud prevention, and mobile app security. Its digital agreement products support secure e-signatures, online notarization, and automated document workflows.
- 🎯 Current $17.87 is 12% below 3yr high $20.23 · ⏳ SMA200 $13.67 (current price $17.87 is above) · 💰 Market Cap $657M
- OSPN passed all filters and shows favorable conditions.

💎 Quality (Q): 39/60
- 🏦 Low drawdown (14.3% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; ROE 25% (>15%); Low LT D/E 0.00 (<1.0); Near-high ROE setup (52wk high + ROE).
⏰ Entry (E): 0/20
- 📈 RSI at 53 in healthy mid-range
📢 Sentiment (S): 5/10
- 🗞️ News sentiment is neutral (mixed coverage; ✅×2 ❌×2).
✅ OneSpan Inc. (OSPN) Discusses Innovations Extending E-Signature Across Digital Agreement Workflows Transcript — Seeking Alpha.
🤖 In an October 14 webinar, OneSpan discussed innovations extending its e-signature offering into broader digital agreement workflows. The product expansion may strengthen its offering and support customer adoption.
✅ OneSpan Expands OneSpan Sign Beyond eSignature Capabilities to Move Customer-Facing Agreements Forward, Faster and With Greater Confidence — Yahoo Finance (Business Wire).
🤖 OneSpan announced new capabilities extending OneSpan Sign beyond e-signatures, including tools intended to streamline agreement completion and improve identity assurance. This broadens the product offering for financial institutions and other organizations.
❌ OneSpan: Muted Growth Prevents A Re-Rating — Seeking Alpha.
🤖 The analysis rates OSPN Hold, citing muted expected growth, declining legacy token revenue, and higher expenses. It forecasts adjusted EBITDA falling in FY26 and remaining flat in 2027, tempering the outlook despite the dividend and debt-free balance sheet.
❌ OneSpan (OSPN) Surpasses Market Returns: Some Facts Worth Knowing — Yahoo Finance.
🤖 The article reports estimates for the upcoming quarter that imply a 33.33% year-over-year decline in EPS, while revenue is expected to edge up only slightly. These are forecasts rather than reported results, and point to earnings pressure.
🍭 Bonus (B): 10/10 — Computer Integrated Systems Design (Technology sector)

🏢 What they do: Laureate Education, Inc. (LAUR) owns and operates a network of higher education institutions in Mexico, Peru, and the United States, offering undergraduate and graduate degree programs in business, medicine, health sciences, engineering, and information technology through campus-based, online, and hybrid formats.
- 🎯 Current $39.04 is 4% below 3yr high $40.46 · ⏳ SMA200 $35.38 (current price $39.04 is above) · 💰 Market Cap $5.4B
- LAUR presents a compelling setup with strong technicals and positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (11.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 51% (>20%); Revenue growth 17% (>15%); ROE 28% (>15%).
⏰ Entry (E): 6/20
- 🔔 SMA20/SMA50 bullish crossover
- 🔔 VWMA trending up (5 consecutive days)
📢 Sentiment (S): 6/10
- 🗞️ News sentiment is positive (mixed coverage; ✅×2 ❌×1 ⚪️×2).
✅ 5 Schools Stocks Navigating Costs and Changing ... — Yahoo Finance.
🤖 The article notes upward revisions to Laureate’s 2026 earnings estimate and expected earnings and revenue growth. These estimates point to a favorable outlook, though the article is not solely about LAUR.
✅ Consumer Discretionary - Education Services Stocks Q2 ... — Yahoo Finance.
🤖 Laureate’s Q2 revenue exceeded expectations, full-year revenue guidance slightly topped forecasts, and management raised its full-year guidance and added $150 million to its share repurchase authorization. These results and capital-return plans are favorable, although the article says the results may already be reflected in the share price.
❌ Laureate Education (NASDAQ:LAUR) Stock Price ... — MarketBeat.
🤖 Morgan Stanley raised its price target from $34.50 to $36.50 but maintained an underweight rating. The higher target is tempered by the bearish rating.
⚪️ Laureate Education surges 79% after Fair Value signal identified opportunity — Investing.com.
🤖 The article reviews the stock’s rise and cites strong Q2 results, higher full-year guidance, and enrollment and margin growth, while also noting JPMorgan’s valuation-related downgrade. Much of the performance described reflects past events rather than a new catalyst.
⚪️ Laureate Education (NASDAQ:LAUR) Receives ... — MarketBeat.
🤖 The article reports a consensus Hold rating and an average price target of $40.50, with four Buy, two Hold, and one Sell rating. The mixed analyst view is broadly balanced.
🍭 Bonus (B): 0/10 — Educational Services

🏢 What they do: CareDx, Inc. is a precision medicine company focused on transplant patients. It develops diagnostics, digital health tools, lab products, and patient support services to help monitor care before and after organ transplantation.
- 🎯 Current $66.67 is 4% below 3yr high $69.85 · ⏳ SMA200 $30.75 (current price $66.67 is above) · 💰 Market Cap $3.4B
- CDNA shows decent technicals supported by positive sentiment.

💎 Quality (Q): 59/60
- 🏦 Low drawdown (12.2% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 1394% (>20%); Revenue growth 52% (>15%); ROE 26% (>15%).
⏰ Entry (E): 0/20
- 🔔 Strong above EMA21 (7.7%)
- 🔔 Strong above EMA50 (21.6%)
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 65 showing strength
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×3 ⚪️×1; showing 3 of 4).
✅ CareDx株が52週高値55.21ドルを記録 — Investing.com.
🤖 The article reports CareDx reaching a 52-week high and recaps quarterly results that beat expectations, alongside an upward revision to full-year guidance. It also notes a valuation concern, but the reported results and guidance are positive catalysts.
✅ CareDx +14% on Fresh $74 Analyst Price Target — Yahoo Finance.
🤖 BTIG raised its price target from $60 to $74 and maintained a Buy rating, citing confidence in the transplant coverage outlook, core business growth, and oncology pipeline. The article says the shares rose about 14% following the analyst update.
⚪️ CareDx (NASDAQ:CDNA) Shares Up 6% - Still a Buy? — MarketBeat.
🤖 The article reports a 6% share-price rise and stronger-than-expected quarterly results, but also notes that analyst ratings are mixed and the average price target is below the current share price. Its discussion is largely a market snapshot rather than a new company-specific catalyst.
🍭 Bonus (B): 0/10 — Medical Laboratories

🏢 What they do: Karat Packaging Inc. manufactures and distributes disposable foodservice products used by restaurants and other foodservice businesses. Its products include food and take-out containers, cups, lids, cutlery, straws, tableware, bags, and compostable packaging, along with related supplies and services.
- 🎯 Current $54.21 is 1% below 3yr high $54.68 · ⏳ SMA200 $33.94 (current price $54.21 is above) · 💰 Market Cap $1.1B
- KRT shows decent technicals supported by positive sentiment.

💎 Quality (Q): 57/60
- 🏦 Low drawdown (13.7% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 170% (>20%); ROE 30% (>15%); Low LT D/E 0.00 (<1.0).
⏰ Entry (E): 0/20
- 🔔 VWMA trending up (5 consecutive days)
- 📈 RSI at 63 showing strength
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ Full Transcript: Karat Packaging Q2 2026 Earnings Call - Karat Packaging (NASDAQ:KRT) — Benzinga.
🤖 The transcript covers the company’s second-quarter results. Those results included adjusted EPS of $1.48, well above analyst expectations, although revenue was slightly below forecasts.
✅ Karat Packaging stock hits all-time high at 55.38 USD — Investing.com.
🤖 The article reports that KRT reached an all-time high, reflecting strong recent share-price momentum. It also notes the substantial second-quarter earnings beat, partly driven by a tariff refund, alongside revenue slightly below analyst forecasts.
✅ Should Karat Packaging’s Online-Driven Earnings Beat Require Action From Karat Packaging (KRT) Investors? — Yahoo Finance.
🤖 The article highlights 9.9% year-over-year revenue growth and results that exceeded analyst expectations for revenue, EPS, and EBITDA. It also discusses more cautious longer-term views, tempering the otherwise favorable earnings news.
🍭 Bonus (B): 0/10 — Rubber & Plastics Products

🏢 What they do: DexCom, Inc. is a medical device company that develops and sells continuous glucose monitoring (CGM) systems for people with diabetes. Its products, including the Dexcom G6 and G7, use wearable sensors and mobile apps to track glucose levels in real time and help users manage their blood sugar.
- 🎯 Current $87.71 is 38% below 3yr high $140.45 · ⏳ SMA200 $73.75 (current price $87.71 is above) · 💰 Market Cap $33.1B
- DXCM shows decent technicals supported by positive sentiment.

💎 Quality (Q): 56/60
- 🏦 Low drawdown (12.1% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 42% (>20%); ROE 38% (>15%); Low LT D/E 0.00 (<1.0).
📢 Sentiment (S): 10/10
- 🗞️ News sentiment is positive (✅×5; showing 3 of 5).
✅ DexCom gains as NEJM publication boosts Medicare coverage hopes — Seeking Alpha.
🤖 Results from Dexcom’s CONNECT trial showed improved glucose outcomes for adults with Type 2 diabetes not using insulin. Analysts said the peer-reviewed findings could support broader Medicare coverage, a potential growth catalyst.
✅ Landmark Dexcom CONNECT Study Published in The New England Journal of Medicine, Redefining the Standard of Care for People with Type 2 Diabetes Not on Insulin — Business Wire.
🤖 Dexcom announced that its CONNECT trial results were published in the New England Journal of Medicine, providing evidence of CGM benefits for adults with Type 2 diabetes who do not use insulin. The findings may strengthen the case for wider adoption and reimbursement.
✅ DexCom (NASDAQ:DXCM) Stock Price Expected to Rise, BTIG Research Analyst Says — MarketBeat.
🤖 BTIG raised its price target on DexCom from $90 to $96 while maintaining a Buy rating. The higher target reflects a more favorable analyst outlook.
🍭 Bonus (B): 0/10 — Surgical & Medical Instruments

🏢 What they do: PC Connection, Inc. (doing business as Connection) is a U.S.-focused information technology solutions provider that helps organizations buy, deploy, secure, and support technology through a value-added reseller and solutions-provider model.
- 🎯 Current $90.82 is 5% below 3yr high $95.22 · ⏳ SMA200 $70.49 (current price $90.82 is above) · 💰 Market Cap $2.3B
- CNXN shows decent technicals supported by positive sentiment.

💎 Quality (Q): 52/60
- 🏦 Low drawdown (11.6% max); EMA21 above EMA50; EMA uptrend sustained 5+ days; EPS growth 35% (>20%); Low LT D/E 0.00 (<1.0); PEG ratio 0.69 (<1.5).
⏰ Entry (E): 5/20
- 🔔 VWMA trending up (5 consecutive days)
- ⚠️ RSI reversing from overbought (55) — BEARISH
📢 Sentiment (S): 9/10
- 🗞️ News sentiment is positive (✅×4 ⚪️×1; showing 3 of 5).
✅ PC Connection names Matt Zafirovski president and COO — Seeking Alpha.
🤖 PC Connection appointed Matt Zafirovski president and COO, effective October 12, while Timothy McGrath remains CEO. The leadership appointment is a company-specific development, though the search result does not describe a financial impact.
✅ PC Connection (NASDAQ:CNXN) Hits New 1-Year High — MarketBeat.
🤖 The article reports that CNXN reached a new 52-week high and cites second-quarter earnings and revenue above analyst expectations. It also notes mixed analyst actions, tempering but not outweighing the positive performance and results.
⚪️ PC Connection chairman & CAO Patricia Gallup sells $1.23m in shares — Investing.com.
🤖 Patricia Gallup reported selling shares on October 5 and 6. This is an insider transaction, not by itself evidence of a change in the company’s outlook or a directional catalyst.
🍭 Bonus (B): 0/10 — Computers & Software - Wholesale